When: Successful retest of $400 with new high

Then: Confirm Overweight; deploy reserved capital

When: Q3 2026 earnings beat with raised guidance

Then: Upgrade to Overweight; full position deployment

When: GD underperforms SPY by >2% over 5 trading sessions without breaking $375

Then: Reassess to Underweight; convert passive Hold to conditional discipline

HOLD existing positions; no new capital at current levels. Wait for either confirmed reclaim of $387.50 with rising volume OR pullback to $365-$354 zone before adding.

• Forward P/E of 20.5x pricing in 13% forward growth against 8.2% four-year EPS CAGR
• Stock at 52-week high with no clear catalyst for multiple expansion until late October
• Technical bearish confluence: 5 consecutive sessions below 10 EMA, 50 SMA at $375.70 with only $3.61 cushion, MACD histogram at -2.41 and accelerating, RSI at 45.73
• Stop at $348 represents 4.7 ATR of risk (ATR $6.62) - 31 points of downside per share
• 200 SMA at $351.70 only 7.3% below current levels; historical corrections in LMT (14%) and NOC (12%) from similar setups
• Goodwill of $22 billion is 35% of total assets - not phantom risk; impairments historically precede 10-15% drawdowns
• Catalyst vacuum removes floor; bad news has outsized impact without offsetting positive news
• Defense super-cycle thesis already priced in over 18 months (stock moved from $306 to $400)
• Market-implied asymmetry from options and technical positioning suggests downside to $348-$354 is at least as probable as upside to $400
• Defensive sector beta of 0.328 means stock won't move quickly; better entry can be waited for
• Opportunity cost of waiting = ~$6 dividend income; cost of being wrong = $31 per share

→ vs aggressive: The ATR-based stop at $348 ($31 per share) is not tight risk management - it represents 4.7 ATR of risk and functions as a prayer for a stock with bearish MACD cross and lower Bollinger Band test

→ vs aggressive: MACD crosses below signal line with accelerating negative histogram (-2.41) and RSI at 45.73 with room to fall is not 'healthy pullback' - it's a bearish confluence with historical precedent of 10-15% extensions in defense primes

→ vs aggressive: The 'conviction breaks before thesis' framing is recency bias justification, not risk management - the actual risk is being wrong at the 52-week high with no catalyst floor

→ vs aggressive: $22 billion in goodwill (35% of assets) is not phantom risk - it's accumulated M&A premiums with real impairment triggers including budget continuing resolutions and defense efficiency reviews

→ vs aggressive: Catalyst vacuum is not a feature - it removes the floor by eliminating positive news flow needed for multiple expansion; bad macro headlines will have outsized impact without offset

→ vs aggressive: Defense super-cycle is 18-month-old news already priced into the stock - it doesn't justify short-term entry at 52-week high with bearish momentum; long-term thesis argues FOR waiting for better entry

→ vs aggressive: Probability-weighted asymmetry claims are unsubstantiated - market-implied probability from options and technicals suggests downside path to $348-$354 is equally or more probable than upside to $400

HOLD existing positions; allow 0.5-1% starter position at current levels with tight stop at $370; reserve bulk of new capital for scaling at $365 and $354; maintain $348 as structural invalidation rather than active stop

• HOLD decision on existing positions is correct given fundamental support, dividend streak, and structural backdrop
• Proposed framework: 2-3% portfolio cap for new capital with 0.5-1% starter at current levels, bulk reserved for $365 and $354
• Tight stop at $370 (just below 50 SMA) for starter position; risk approximately $9/share or 1.4 ATR
• Rising VWMA signals institutional accumulation on up-days, supporting bullish resolution
• Bearish technical cluster: MACD cross below zero, histogram at negative 2.41, RSI at 45.73, price below 10 EMA for five sessions
• Lower Bollinger Band test at $375.70 with $3.61 of cushion is a real support test
• Polymarket data: 89% odds of no Fed cuts in 2026, 8% recession odds—supports defense primes via stable DoD appropriations
• Q2 EPS up 13.4% versus 8.2% four-year CAGR is constructive; 17.8% ROE is a quality franchise
• Bounded risk window: known catalyst eight weeks out (late October Q3 earnings) removes open-ended vacuum concern
• $348 is structural invalidation level for overall thesis, not an active stop for starter position

→ vs aggressive: Goodwill impairment risk is conditional not active—current performance doesn't prove impairment won't occur; conflating 'business is good' with 'risk doesn't exist' is flawed methodology

→ vs aggressive: Probability-weighted asymmetry claim lacks empirical basis—no options pricing, institutional flow data, or historical analog cited; subjective conviction is not analysis

→ vs aggressive: Catalyst vacuum framing is wrong—silence is exposure at 52-week high testing lower Bollinger with bearish MACD cross, not a feature

→ vs conservative: LMT 14% correction and NOC 12% correction comparisons are anecdotal pattern matching, not statistical evidence; defense primes correct at different rates based on contract mix

→ vs conservative: Zero new capital at current levels is too rigid—implies certainty about near-term direction that no one possesses; risks missing entry entirely if stock reclaims $387.50

→ vs conservative: Perfect entry cost basis theory ignores behavioral reality—most investors who wait for ideal levels either don't execute, hesitate, or chase higher prices